DefiniGEN and Atelerix Collaborate to Ship In Vitro Cell Models Internationally Without the Need for Freezing or Cryopreservation
CAMBRIDGE, England & NEWCASTLE, England–(BUSINESS WIRE)–DefiniGEN Ltd., and Atelerix Ltd., today announced they have successfully shipped in vitro... Read more.
Chatham Lodging Trust Provides Business Update
April and May RevPAR Trend Well Above Second Quarter Guidance WEST PALM BEACH, Fla.–(BUSINESS WIRE)–Chatham Lodging Trust (NYSE: CLDT), a hotel real... Read more.
KalVista Pharmaceuticals Presents Data on Persisting Unmet Needs in Hereditary Angioedema at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2024
– Patient perspectives reveal the challenges of injecting on-demand therapies and the consequences of delayed or withheld treatment – – Physicians characterize... Read more.
Ault Alliance Announces Plans to Issue a Special Preferred Artificial Intelligence Data Center and Bitcoin Mining Dividend to Stockholders
LAS VEGAS–(BUSINESS WIRE)–$AGREE #18000_Bitcoin_mining_units_operating—Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company... Read more.
Edwards Lifesciences to Sell Critical Care to BD
Agreement strengthens Edwards’ strategy to advance structural heart innovation IRVINE, CA–(BUSINESS WIRE)–Edwards Lifesciences (NYSE: EW) today announced... Read more.
Forbright Bank Announces New High Yield Savings Account
Customers are eligible for an America the Beautiful National Parks and Federal Recreational Lands Pass as they save for their future and support a better tomorrow... Read more.
Shining Bright atop Taipei 101, GIGABYTE Redefines AI Evolution Accelerated by Next-Generation Computing at COMPUTEX
TAIPEI–(BUSINESS WIRE)–#ACCEVOLUTION–Renowned globally for its research and development capabilities, GIGABYTE Technology will exhibit its products... Read more.
Summit Raises $200 Million; Also Expands License Territories for Ivonescimab
$200 Million in Net Proceeds Raised at Premium to Previous Closing Price In Separate Transaction, Summit Expanded License Territories for Ivonescimab in Deal with... Read more.
Uncategorised
Positive Results from Genethon’s Gene Therapy Trial for Duchenne Muscular Dystrophy, Advances of Its Spinoff Atamyo in the LGMD and Cardiomyopathy Fields, Highlighted in Latest Newsletter
PARIS–(BUSINESS WIRE)–Genethon, a unique non-profit gene therapy R&D organization founded by the French Muscular Dystrophy Association (AFM-Telethon),... Read more.
Diakonos Oncology CFO Anthony Baldor to Provide Corporate Update at BIO International Convention In San Diego, June 3 – 6, 2024
Presentation will include review of the company and its unique autologous dendritic cell vaccines for cancer, including clinical data and an operational update.... Read more.